Amplimune™ (100-dose)

Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is CFIA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.

Amplimune™ (20-dose)

Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is CFIA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.

Amplimune™ (5-dose)

Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is CFIA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.

Immunocidin® (canine)

Immunocidin, mycobacterium cell wall fraction (MCWF) immunostimulant, is CFIA-approved for the intratumoral treatment of mixed mammary tumor and mammary adenocarcinoma in dogs.

Immunocidin® (equine)

Immunocidin, mycobacterium cell wall fraction (MCWF) immunostimulant, is CFIA-approved for the intratumoral treatment of sarcoid tumors in horses.